Gastroenterology



Gastroenterology


Paritosh Prasad

Bradley Monash

Jess Kaplan

Garrett C. Zella

Jeffrey A Biller



Acute Abdominal Pain


Definition

(Silen W. Cope’s Early Diagnosis of the Acute Abdomen. 20th Ed. Oxford Univ. Press. 2000)



  • Abd pain 2/2 activation of visceral nerves (innervate hollow viscera & mesentery; poorly localizing), or somatic nerves (innervate parietal peritoneum; focal).



    • Parietal inflammation can be 2/2 worsening underlying visceral inflammation; presenting w/ generalized abd pain, which progressively localizes.


  • Pain can be referred to abd from other structures (i.e., pleuritis in lower lobe PNA, Strep. pharyngitis). (Pediatr Clin North Am 2006;53:107)


Clinical Manifestations

(BMJ 1969;1:284)



  • History w/ assoc sxs, signs, & physical are important to narrow differential


  • Concerning sx: Anorexia (appendicitis), bilious emesis (obstruction), rebound or guarding (peritonitis), assoc findings of palpable purpura (HSP) or ecchymosis on abdomen or back (pancreatitis). Fever can be concerning but nonspecific.


  • Localized pain can be helpful for localization, but is often nonspecific.



    • RUQ: Gall bladder or hepatic/peri-hepatic disease, RLL PNA


    • LUQ: Stomach, LLL PNA, splenic dz.


    • Epigastrium: Stomach, small bowel, pancreatitis, mesenteric ischemia


    • RLQ: Appendicitis (starts periumbilical), ovarian disease in female, colitis


    • LLQ: Colitis, ovarian disease in female


    • Suprapubic: UTI, PID


    • Radiating pain: To testicles or labia (nephrolithiasis), to back (pancreatitis)


Etiology

(Pediatr Clin North Am 2006;53:107)



  • Etiologies and working differential varies based on age. See specific topics for Rx.



    • Gastroenteritis (viral) & constipation most common benign causes for all ages


    • Appendicitis (see ED chapter); dx in 82% of children admitted w/ abd pain



      • Higher rates of perforation in children. Often mistaken for gastroenteritis.


    • Intussusception (see ED chapter); most frequent btw 3 mo–5 yr, 60% w/i 1st yr



      • Peak btw 6–11 mo. 60% p/w 2 of 3; abd pain, vomiting, bloody mucous stool


    • Small bowel obstruction: Multi etiologies, most common 2/2 adhesions from prior surgery or incarcerated hernia; p/w abd pain, vomiting (bile), distention


    • Incarcerated hernia: 60% inguinal (R side) in 1st yr; p/w groin bulge.


    • Malrotation w/ midgut volvulus: Highest incidence in 1st mo; often abd pain and bilious vomiting, but can be insidious. Surgical emergency


    • Necrotizing enterocolitis: Preterm but in full term as well; present in extremis


Diagnostic Studies



  • Evaluation is dependent on history (associated symptoms & signs) & physical exam


  • PMH of abd surgery raises risk of incarcerated hernia or obstruction 2/2 adhesion


  • Always consider the possibility of child abuse.


Peptic Ulcer Disease (PUD)


Definition



  • Damage to mucosal lining of upper GI tract 2/2 imbalance btw protective fxn of mucus and bicarb secretion and damage from gastric acid and pepsin, +/- external factors (NSAIDs, EtOH, other mucotoxic agents) or H. pylori infection.


Pathology

(Pediatr Rev 2001;22:349)



  • Acid secretion is mediated by stimulation of parietal cells by acetylcholine (vagal), histamine, and gastrin (Zollinger-Ellison syndrome).


  • H. pylori (gram neg spiral rod) adapted to mucous layer; infxn possibly resulting in damage of intestinal mucosa 2/2 urease secretion (hydrolyzes urea to ammonia and bicarbonate) disrupts epithelial cell fxn; +/- vacuolating cytotoxin.



Epidemiology

(J Pediatr 2005;146:S21)



  • H. pylori w/ ∼ 50% prevalence worldwide (from 10% [U.S. avg] to 80% w/ higher rates in lower socioeconomic groups); only 10%–15% infected develop PUD


  • Evidence suggests acquisition of H. pylori infection occurs in childhood (by 5–10 yo)


  • There is often a family history of peptic ulcer disease; unclear why


  • Other etiologies less common overall (can be more prevalent in inpts); stress related (severe illness, burn), 2/2 ↑ ICP (Cushing ulcer) or 2/2 NSAID and other drugs.


Clinical Manifestations

(Pediatr Rev 2001;22:349)



  • Generally p/w recurrent epigastric pain and can be assoc w/ postprandial or nocturnal abd pain, vomiting or food regurgitation.


  • In severe cases can present with failure to thrive, upper GI bleed, or chronic anemia.


  • Controversial whether H. pylori infxn can cause acute abd pain; NSAID- and drug-induced gastritis and ulcer formation can. (Pediatrics 1999;103:192)


Diagnostic Studies

(J Pediatr 2005;146:S21)



  • Initial eval w/ CBC diff (assess for anemia), ESR (IBD), LFTs, electrolytes (if recurrent vomiting), and stool evaluation for O and P (if exposure/diarrhea)


  • If PUD suspected, send H. pylori IgG; can’t distinguish btw current & prior infxn.



    • Sens 54%–94%, spec 59%–97% (assay dependent); neither sens nor spec in children 2/2 lower titer cutoffs, shorter durations of infection.


  • Stool antigen testing where available is highly sensitive (98%) and specific (99%)


  • Urea breath testing (UBT): Radio-labeled urea is ingested and then CO2 exhalation is measured; good functional test and can be used to assess for cure



    • Less widely used in children 2/2 concerns about radiation


    • Can see false +, especially <3 yo, 2/2 discoordinated swallow (oral bacteria w/ urease too) Can see false-neg if patient is already on Rx (acid suppression)


  • Gold standard upper GI endoscopy and bx, radiographic UGI studies less sensitive


Treatment

(J Pediatr Gastroenterol Nutr 2000;31:490)



  • If H. pylori +; rx w/ PPI (1–2 mg/kg/d) w/ any 2 of the following; amoxicillin 50 mg/kg/d, clarithromycin 15 mg/kg/d, and/or metronidazole 20 mg/kg/d


  • Studies show 75%–80% cure rate w/ 7 d of triple therapy, suggesting rx for 14 d


Complications

(J Pediatr 2005;146:S21)



  • Atrophic gastritis +/- metaplasia; high risk if PPI use w/o eradication; gastric CA risk


  • Gastric CA: Seen in 1% of H. pylori infected, likely via above mechanism


  • Gastric mucosa-associated lymphoid tissue lymphoma (MALT): Rarer, only 0.1%


Vomiting


Definition



  • Reverse peristalsis 2/2 activation of vomiting center (VC) in medulla or chemoreceptor trigger zone (CTZ) in area postrema (floor IVth ventricle).


Etiology

(Pediatr Rev 1998;19:337)

See Chart on next page


Clinical Manifestations



  • Assess for dehydration; Mod (5%–10% BW) w/ irritability, cool ext, dry mucous membranes, sunken eyes, dec skin turgor (1–2 sec skin pinch), Severe (>10% BW) w/ lethargy, >2 sec skin pinch, cold ext, deep acidotic breathing, HoTN, tachy.





image



Diagnosis & Treatment

(Am Fam Physician 2000;61:2791; J Pediatr Gastroenterol Nutr 2001;32:S12)



  • Definitive management as well as diagnostic testing depends on underlying etiology.


  • Nonbilious emesis: Generally less concerning; some emergencies, pyloric stenosis


  • Bilious emesis is almost always concerning sx warranting further evaluation.



    • NGT placement for decompression if obstruction suspected.


    • Diagnostic evaluation varies but generally includes KUB and/or UGI.


    • W/ neonate, bilious emesis can indicate surgical disease.


    • Duodenal atresia: Congenital obstruction of 2nd part of duodenum, 2/2 failure to recanalize in utero, vomiting w/i hrs; pregnancy often w/ polyhydramnios



      • 1 in 5000–10,000 and M>F, seen in 1/4 Down’s syndrome pts, 20% w/ CDH


      • Membranous or interrupted lesion at papilla of Vater (PV), 80% w/ PV open to proximal duodenum resulting in bilious emesis.


      • KUB w/ “double bubble”: Gastric air bubble and distended prox duodenum


      • Surgery necessary but not urgent (<48 hr) if decompressed w/ NGT and IVFs


    • Midgut malrotation and volvulus: Midgut rotated clockwise around SMA/V, can cause obstruction/ischemia/infarction.



      • Usually p/w volvulus in 1st 3–7 d w/ bilious emesis +/- abd distention; majority w/i 1st yr of life but can present at older age (recurrent abd pain)


      • Imaging; US w/ jejunal “spiral” or UGI w/ malpositioned SMA/V or ligament of Treitz (normally to L of spine)


      • Needs urgent surgery (separation of Ladd band); if early excellent prognosis


      • Complications: 2/2 gut ischemia → resection and short gut syndrome


    • Jejunoileal atresia: Mesenteric vascular accident in utero → segmental infarct



      • 4 types abnormalities: Membranous, interrupted, apple peel, and multiple


      • All w/ same sx; abd distention and bilious emesis w/i 1st 24 hr.


      • Abdominal films w/ air-fluid levels proximal to obstruction


      • Can be complicated by meconium peritonitis; intense inflammation resulting in calcifications, vascular fibrous proliferation, and cyst formation


    • Meconium ileus: 90%–95% have CF, but only 15% pts CF have hx of mec ileus.



      • KUB w/ distended loops, thickened wall, filled w/ “ground glass.”


      • Can rx w/ Gastrograffin (successful in 16%–50%).


  • Treatment of nausea: (N Engl J Med 2005;352:817) based on etiology



    • GI tract irritation or distention: Via vagal and/or glossopharyngeal afferents (i.e., 2/2 constipation, NSAIDs, mucositis 2/2 chemo), stimulated via 5HT3R; rx with ondansetron, (5HT3R blocker) steroids to dec inflammation (mucositis)


    • Vestibular tract irritation (i.e., labyrinthitis): Stimulated via H1R and muscarinic receptors; rx w/ antihistamine or anticholinergics


    • CTZ; sampling blood for emetogens (BBB absent here): Stimulated via D2R



      • Emetogens can be endogenous (tumor, azotemia, HoNa) or exogenous (opioids, chemo); rx w/ haloperidol > phenothiazines (compazine)


    • Higher CNS center involvement: Can activate or suppress; rx anxiolytics


    • All stimulate VC (final common pathway): Stimulated by parasymp and H1R, acts via parasymp and motor efferents


Gastroesophageal Reflux Disease (GERD)


Definition

(Pediatr Rev 2007;3:101)



  • Passage of gastric contents to esophagus, can be nml (GER), or pathologic (GERD).


Pathophysiology



  • Intermittent relaxation of LES, acid refluxing to esophagus w/ esophagitis, chronically causes change from columnar to squamous (Barrett)


Epidemiology



  • Prevalence physiologic reflux ∼50% at 0–3 mo, 67% by 4 mo, 5% at 12 mo, and in children 3–17 yo, rates vary from 1.4%–8.2%


Clinical Manifestation:

Varies by age



  • Infants: Vomiting, FTT, irritability, asthma, ALTE, recurrent PNAs


  • Children/adolescent: Abd pain retrosternal CP, dysphagia, regurg, asthma/cough



Diagnostic Studies



  • H&P only, unless complications present or dx in question


  • UGI: Not sensitive or specific for GERD but identifies malro, esophageal/antral webs, pyloric stenosis, Schatzki rings, hiatal hernia.


  • Esophageal pH probe: Checks freq and duration of acid exposure. Reflux index = % time Ph <4 (most valid tool), upper nml 0–11 mo 11.7%, 1–9 yo 5.4%, adults 6%


  • Endoscopy: Visualize and bx esophagus and duodenum for inflamm and complications


  • Empiric Rx: widely used but not validated for any sx presentation in children


Treatment –

(J Pediatr Gastroenterol Nutr 2005;41:S41)



  • Evidence for 2 wk trial of hypoallergenic formula for formula fed infants


  • Thickening agents do not improve reflux index, do dec # of vomiting events


  • Positioning (if >1 yr): Left-side positioning and elevation of head of bed in sleep


  • Lifestyle Δ (child/adoles): No caffeine, chocolate, spicy food, tobacco, EtOH


  • Acid suppression: PPIs >H2RAs; if long-term PPI, check for H. pylori (risk of atrophic gastritis w/ chronic >6 mo PPI use and untreated H. pylori)



    • Space dosing of PPIs and H2RAs as H2RA may inhibit PPI efficacy


    • Majority of children develop tachyphylaxis to H2RAs


    • There is evidence we are over prescribing (Pediatrics 2007;120:946)


  • Prokinetic: Aside from cisapride (limited access) no prokinetics show benefit


  • Surgical Rx: Case series show generally favorable outcomes.


Prognosis:

Most outgrow sx by 12 mo; poorer prognosis w/ neuro impairment, esophageal atresia, prematurity.


Complications



  • Respiratory (asthma, apnea, ALTE, cough), ENT (sinusitis, dental erosions, laryngitis), esophageal strictures, Barrett, adenoCA, UGI bleeding.


  • ∼2/3 of children w/ asthma improve to some degree w/ rx for GERD


  • Neurologically impaired at high risk of recurrent aspiration (PNA, pulm fibrosis)


Pyloric Stenosis


Definition

(Pediatr Rev 2000;21:249)



  • Gastric outlet obstruction 2/2 hypertrophy and edema of pyloric canal, and antropyloric muscle spasm → vomiting, dehydration and hypochloremic, hypokalemic, metabolic alkalosis; thought to be an acquired condition.


Epidemiology



  • Incidence of 1 in 250–1000, M 4–8×’s > F, caucasian predilection


Clinical Manifestations



  • Mean age 3 wk, but anytime birth to 5 mo; begins w/ regurgitation → nonbilious vomiting +/- projectile vomiting


  • Classically w/ “olivelike” mass palpated in epigastric region, pathognomonic; not always appreciable; exam enhanced by NGT decomp and prone positioning


Diagnostic Studies



  • US is study of choice, pyloric thickness >4 mm, length >16 mm w/ sens 89%, spec 100%; may need repeat US given operator variability.


  • Most common cause of metabolic alkalosis in infancy; hypochloremic metabolic alkalosis 2/2 acid loss from vomiting and decreased HCO3 secretion.


  • Excess bicarb can be excreted in urine w/ obligate Na loss, followed by H2O, also 2° hyperaldo 2/2 inc renin release causes distal H+ secretion and paradoxic aciduria.


  • Can have low or nml K but usually total body K depletion


Treatment



  • Reverse metabolic derangements and volume status.


  • Pyloromyotomy is curative, incision through serosa and mucosal layer.


Gastrointestinal Bleeding


Definition



  • Intraluminal bleeding at any site from oropharynx to the anus; definition of upper GI bleed as proximal to the ligament of Treitz and lower GI bleed as distal.



  • Can p/w bloody vomit (hematemesis), “coffee ground” emesis, hematochezia (BRBPR; LGIB or rapid UGIB (>20% blood volume)) or melana (tarry black 2/2 digestion, darkness correlates w/ time to pass); R/o other site (nasopharynx).


  • Check for false coloring; red food coloring, fruit juice, beets can make vomit or stool red; Pepto-Bismol, iron, grape juice, spinach, and blueberry can make it black.


Etiology of Upper GI Bleed

(Clin Pediatr (Phila) 2007;46:16)

Differential of UGIB




image


Etiology of Lower GI Bleed –

(Pediatr Emerg Care 2002;18:319)



  • Anal fissure: Most common cause LGIB <2 yo. Blood coated stool. Painful.


  • Food allergy: 3 different mechanisms; cow’s milk and soy most likely offenders



    • Enterocolitis: Vomiting, bloody diarrhea; +/- malabsorption, FTT


    • Colitis: 1st few mo of life, healthy, normal weight w/ blood in stool


    • Eosinophilic gastroenteritis: Infiltration w/ eos, peripheral eos, no vasculitis, p/w postprandial N/V, abd pain, watery diarrhea +/- blood, anemia, FTT


  • Necrotizing enterocolitis: Risk factors, prematurity, sepsis, LBW, HoTN, asphyxia


  • Infectious enterocolitis: Bacterial, viral, or parasitic pathogens. C. diff w/ Abx hx.


  • Hirschsprung disease: 10%–30% develop enterocolitis w/ fever, bloody diarrhea


  • Meckel diverticulum: 2/2 incomplete obliteration of omphalomesenteric duct



    • Painless passage of large amt of blood; otherwise healthy (2/2 heterotopic gastric mucosa in diverticulum causing adjacent ileal mucosa ulceration)


    • “Rule of 2s”; 2% pop, 2 inches long, 2 cm diameter, w/i 2 ft of ileocecal junction, w/ types of ectopic tissue (gastric and pancreatic), 2:1 M:F, and sx’s before 2 yo


    • Duplication of bowel same as Meckel but on mesenteric side, not antimesenteric


  • Intussusception: Usually <2 yo, colicky abd pain, “sausage shaped” abd mass w/ late finding of “currant jelly stool.” See ED Chapter.


  • Polyps: Outside of infant age group these are the most common source for LGIB



    • Painless rectal bleeding


    • Juvenile polyps are 90% hamartomatous (benign) usually singular but multiple seen in juvenile polyposis, Peutz-Jeghers (mucocutaneous pigmentation; higher rate GI CA but not 2/2 polyps) and Cowden syndrome


    • Adenomatous polyps can be premalignant; found in familial polyposis (AD but 1 in 3 new mutation; sx after 10 yo), Gardner syndrome (AD; soft tissue/bone tumors) and Turcot syndrome.


  • IBD: Almost all UC and ¼ of Crohn have LGIB, 1 in 4 present before 20 yo


  • Angiodysplasia: Vascular ectasia; assoc syndromes (Osler-Weber-Rendu, Turner)


  • Hemorrhoids: Rare in childhood, assess for portal HTN; common after adolescence


  • Henoch-Schönlein purpura: Typically 4–7 yo (but any age) systemic small vessel vasculitis w/ abd pain and bloody stools, “palpable purpura.” +/- renal and joint



    • GI involvement in 45%–75% cases and can precede skin findings in 15% of cases


    • IgA immune complex mediated


  • HUS: Microangiopathic hemolytic anemia, thrombocytopenia, ARF usually preceded by bloody diarrhea. (90% D+HUS w/ shiga-like toxin vs. atypical HUS/D-HUS w/o)



Clinical Manifestations



  • Tachycardia most sensitive sign of acute, severe blood loss


  • HoTN and decreased capillary refill are ominous late findings (>30% blood vol loss)


  • With infants who are breast-feeding, ask mother about presence of breast lesions


  • Hemorrhagic disease of newborn; hx. child born at home, no Vit K presents DOL 1–5


  • Variceal bleed 2/2 extrahepatic portal HTN; no cirrhotic stigmata, + splenomegaly



    • Extrahepatic portal HTN 2/2 omphalitis 2/2 neonatal umbilical vein catheter or spontaneous inflammation of umbilical vessels.


  • Check skin for petechiae or purpura (coagulopathy or HSP), spider angiomata (liver dz), hemangiomas or telangiectasias (Osler-Weber-Rendu).


Diagnostic Studies



  • Confirm w/ hemoccult for stool guaiac or gastroccult w/ vomitus


  • False neg w/ vit C, false + w/ red meat, veg w/ peroxidase (broccoli, radish, turnips)


  • NGT lavage useful if returns blood/coffee grounds = UGIB; can miss duodenal ulcer


  • Isolated increase in BUN can be a sign of gastric bleeding and absorption


  • Plain films: KUB/upright for free air (perforation), pneumatosis intestinalis (NEC), air fluid levels (obstruction).


  • Upper GI and small bowel follow through best for structural lesions.


  • Endoscopy: Indicated w/ acute UGIB necessitating transfusion or recurrent bleeding or as first step in evaluation of LGIB; contraindicated in clinically unstable patient



    • Retrospective studies show w/ EGD 5 most common dx = duodenal ulcer (20%), gastric ulcer (18%), esophagitis (15%), gastritis (13%), and varices (10%) in children and adolescents (Pediatrics 1979;63:408).


  • Rectosigmoidoscopy/Colonoscopy: Useful if not active major bleeding



    • Most helpful to assess IBD, angiodysplasia, polyps, pseudomembranous colitis.


  • Barium enema: For Hirschsprung dz, IBD, polyps, dx and rx of intussusception.


  • Nuclear medicine (Technetium-99 pertechnetate): Labels ectopic gastric mucosa, best for Meckel diverticulum or intestinal duplication.



    • Can also do Technetium-99 RBC scan for bleeding (0.05–0.1 mL/min)


  • Angiography: Must be >0.5 mL/min for detection



    • Can be used for therapeutic approach, i.e., coiling


    • Indicated over EGD for hemobilia (bleeding from biliary tract)


  • Abdominal US +/- Doppler: For specific evaluation (i.e., liver dz or portal HTN)


  • In immune compromised consider assessment for CMV, HSV, or Candida esophagitis


Treatment



  • Acute management: Volume resuscitation w/ 2 large bore IVs, IV bolus w/ NS or LR, transfusion, if present correct coagulopathies (FFP, platelets)


  • UGIB: Basically 2 sources (1) Mucosal (-itis, ulcers, Mallory-Weiss) (2) Variceal



    • Mucosal: Neutralize/decrease acid production (PPIs > H2RA); w/ Mallory-Weiss can coagulate w/ thermal probe or inject dilute epinephrine


    • Variceal: Acute bleeding stops spontaneously in 50% w/ rebleed in 40%



      • Stop bleeding (band ligation > sclerotherapy by risk profile)


      • Decrease portal pressure and splanchnic blood flow: octreotide > vasopressin


  • LGIB: Etiology specific (stool softeners for fissure, Abx for infectious colitis)


Acute Diarrhea


Definition

(Pediatr Rev 1989;11:6)



  • > nml stool output (>10 cc/kg/d), usually ↑ # BMs/d; WHO crit >3 stools/d.


  • Young infants have intestinal mucosa permeable to water; have greater net fluid loss.


  • 80% fluid absorption at small bowel; processes affecting SB have rapid dehydration


Pathophysiology

(Arch Dis Child 1997;77:201)



  • 4 basic processes: secretory, cytotoxic, osmotic, and inflammatory


  • Secretory: 2/2 infectious enterotoxin (cholera), metabolic/endocrine (hyperthyroid, VIPoma, ZES), or exogenous toxic agent (colchicines)



    • Enterotoxin → ↑secretion fluids/lytes via mucosal crypt cells or blocks villi absorp


  • Cytotoxic: 2/2 destruction of mucosal cells of small intestine, generally 2/2 viral infection (rota, Norwalk), similar underlying changes in celiac disease



  • Osmotic: Seen in malabsorptive conditions, unabsorbed substance in lumen reaches osmotically active concentration causing water influx. (i.e., lactose intolerance)



    • Determined by fecal osmotic gap (FOG) = serum osm – 2(stool Na + stool K)


    • FOG >100–120 is osmotic diarrhea; use serum osm to avoid error 2/2 transit time. If serum osm unavailable, can use stool Osm but less accurate


  • Inflammatory: 2/2 damage to intestinal lining w/ bloody stools, fecal leukocytes, and tenesmus, generally involves large intestine and terminal ileum



    • Invasive organisms: Yersinia, Campylobacter, Salmonella, Shigella, EHEC


Etiology




image


History



  • Hx recent consumption raw milk, salad, undercooked meat/poultry, unpurified H2O, recent Abx, immunocompromise, sick contacts, FHx GI dz (IBD), blood in stool

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Gastroenterology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access